These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 9408950)
1. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl. Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950 [TBL] [Abstract][Full Text] [Related]
2. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl. Tzeng SR; Lou YC; Pai MT; Jain ML; Cheng JW J Biomol NMR; 2000 Apr; 16(4):303-12. PubMed ID: 10826882 [TBL] [Abstract][Full Text] [Related]
3. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. Cory GO; Lovering RC; Hinshelwood S; MacCarthy-Morrogh L; Levinsky RJ; Kinnon C J Exp Med; 1995 Aug; 182(2):611-5. PubMed ID: 7629518 [TBL] [Abstract][Full Text] [Related]
4. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238 [TBL] [Abstract][Full Text] [Related]
5. Stability and folding of the SH3 domain of Bruton's tyrosine kinase. Chen YJ; Lin SC; Tzeng SR; Patel HV; Lyu PC; Cheng JW Proteins; 1996 Dec; 26(4):465-71. PubMed ID: 8990499 [TBL] [Abstract][Full Text] [Related]
6. The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS. Guinamard R; Fougereau M; Seckinger P Scand J Immunol; 1997 Jun; 45(6):587-95. PubMed ID: 9201297 [TBL] [Abstract][Full Text] [Related]
7. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. Yang W; Malek SN; Desiderio S J Biol Chem; 1995 Sep; 270(35):20832-40. PubMed ID: 7657668 [TBL] [Abstract][Full Text] [Related]
8. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia. Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059 [TBL] [Abstract][Full Text] [Related]
9. Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase. Ma YC; Huang XY Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12197-201. PubMed ID: 9770463 [TBL] [Abstract][Full Text] [Related]
10. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis. Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312 [TBL] [Abstract][Full Text] [Related]
11. Both proline-rich sequences in the TH region of Bruton's tyrosine kinase stabilize intermolecular interactions with the SH3 domain. Hansson H; Smith CI; Härd T FEBS Lett; 2001 Nov; 508(1):11-5. PubMed ID: 11707259 [TBL] [Abstract][Full Text] [Related]
12. Intermolecular interactions between the SH3 domain and the proline-rich TH region of Bruton's tyrosine kinase. Hansson H; Okoh MP; Smith CI; Vihinen M; Härd T FEBS Lett; 2001 Jan; 489(1):67-70. PubMed ID: 11231015 [TBL] [Abstract][Full Text] [Related]
13. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA). Vihinen M; Mattsson PT; Smith CI Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316 [TBL] [Abstract][Full Text] [Related]
14. The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto-phosphorylated in vitro. Morrogh LM; Hinshelwood S; Costello P; Cory GO; Kinnon C Eur J Immunol; 1999 Jul; 29(7):2269-79. PubMed ID: 10427990 [TBL] [Abstract][Full Text] [Related]
15. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk. Vihinen M; Nore BF; Mattsson PT; Bäckesjö CM; Nars M; Koutaniemi S; Watanabe C; Lester T; Jones A; Ochs HD; Smith CI FEBS Lett; 1997 Aug; 413(2):205-10. PubMed ID: 9280283 [TBL] [Abstract][Full Text] [Related]
16. Solution structure of the SH3 domain from Bruton's tyrosine kinase. Hansson H; Mattsson PT; Allard P; Haapaniemi P; Vihinen M; Smith CI; Hard T Biochemistry; 1998 Mar; 37(9):2912-24. PubMed ID: 9485443 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK). Matsushita M; Yamadori T; Kato S; Takemoto Y; Inazawa J; Baba Y; Hashimoto S; Sekine S; Arai S; Kunikata T; Kurimoto M; Kishimoto T; Tsukada S Biochem Biophys Res Commun; 1998 Apr; 245(2):337-43. PubMed ID: 9571151 [TBL] [Abstract][Full Text] [Related]
18. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia. Saha BK; Curtis SK; Vogler LB; Vihinen M Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of Bruton's tyrosine kinase by c-Abl. Bäckesjö CM; Vargas L; Superti-Furga G; Smith CI Biochem Biophys Res Commun; 2002 Dec; 299(3):510-5. PubMed ID: 12445832 [TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein. Yamadori T; Baba Y; Matsushita M; Hashimoto S; Kurosaki M; Kurosaki T; Kishimoto T; Tsukada S Proc Natl Acad Sci U S A; 1999 May; 96(11):6341-6. PubMed ID: 10339589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]